Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.2113
H.R.2113: Speeding Access to Already Approved Pharmaceuticals Act of 2017
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced April 20, 2017
- Latest Major Action April 21, 2017
- See the two similar bills introduced in other congresses.
Bill Sponsor
Bill Version
- Introduced in House - April 20, 2017
Bill Summary
Speeding Access to Already Approved Pharmaceuticals Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration to facilitate the development and expedite the review of a new drug, biological product, or medical device that has been approved in the European Union.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| April 21, 2017 |
Referred to the Subcommittee on Health.
|
| April 20, 2017 |
Referred to the House Committee on Energy and Commerce.
|
| April 20, 2017 |
Introduced in the House by Steve Stivers (R-Ohio) |